• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[轻度至中度慢性阻塞性肺疾病急性加重期全身炎症的病因及生物标志物]

[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].

作者信息

Saldías P Fernando, Díaz P Orlando, Dreyse D Jorge, Gaggero B Aldo, Sandoval A Christian, Lisboa B Carmen

机构信息

Servicio de Medicina Interna, Hospital San Juan de Dios, Santiago, Chile.

出版信息

Rev Med Chil. 2012 Jan;140(1):10-8. Epub 2012 Apr 12.

PMID:22552550
Abstract

BACKGROUND

The etiology of acute exacerbations of chronic obstructive pulmonary disease (COPD) is heterogeneous and still under discussion. Inflammation increases during exacerbation of COPD. The identification of inflammatory changes will increase our knowledge and potentially guide therapy.

AIM

To identify which inflammatory parameters increase during COPD exacerbations compared to stable disease, and to compare bacterial and viral exacerbations.

MATERIAL AND METHODS

In 85 COPD patients (45 males, mean age 68 ± 8 years, FEV1 46 ± 17% of predicted) sputum, nasopharyngeal swabs and blood samples were collected to identify the causative organism, during a mild to moderate exacerbation. Serum ultrasensitive C reactive protein (CRP), fibrinogen and interleukin 6 (IL 6), neutrophil and leukocyte counts were measured in stable conditions, during a COPD exacerbation, 15 and 30 days post exacerbation.

RESULTS

A total of 120 mild to moderate COPD exacerbations were included. In 74 (61.7%), a microbial etiology could be identified, most commonly Mycoplasma pneumoniae (15.8%), Rhinovirus (15%), Haemophilus influenzae (14.2%), Chlamydia pneumoniae (11.7%), Streptococcus pneumoniae (5.8%) and Gram negative bacilli (5.8%). Serum CRP, fibrinogen and IL 6, and neutrophil and leukocyte counts significantly increased during exacerbation and recovered at 30 days post exacerbation. Compared to viral exacerbations, bacterial aggravations were associated with a systemic inflammation of higher magnitude.

CONCLUSIONS

Biomarkers of systemic inflammation increase during mild to moderate COPD exacerbations. The increase in systemic inflammation seems to be limited to exacerbations caused by bacterial infections.

摘要

背景

慢性阻塞性肺疾病(COPD)急性加重的病因具有异质性,仍在讨论中。COPD加重期间炎症会增加。识别炎症变化将增加我们的认识,并有可能指导治疗。

目的

确定与稳定期疾病相比,哪些炎症参数在COPD加重期间会增加,并比较细菌和病毒引起的加重情况。

材料和方法

在85例COPD患者(45例男性,平均年龄68±8岁,FEV1为预测值的46±17%)中,在轻度至中度加重期间收集痰液、鼻咽拭子和血液样本以确定病原体。在稳定期、COPD加重期间、加重后15天和30天测量血清超敏C反应蛋白(CRP)、纤维蛋白原和白细胞介素6(IL-6)、中性粒细胞和白细胞计数。

结果

共纳入120例轻度至中度COPD加重病例。在74例(61.7%)中,可以确定微生物病因,最常见的是肺炎支原体(15.8%)、鼻病毒(15%)、流感嗜血杆菌(14.2%)、肺炎衣原体(11.7%)、肺炎链球菌(5.8%)和革兰氏阴性杆菌(5.8%)。血清CRP、纤维蛋白原和IL-6以及中性粒细胞和白细胞计数在加重期间显著增加,并在加重后30天恢复。与病毒引起的加重相比,细菌引起的加重与更高程度的全身炎症相关。

结论

在轻度至中度COPD加重期间,全身炎症的生物标志物会增加。全身炎症的增加似乎仅限于由细菌感染引起的加重。

相似文献

1
[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].[轻度至中度慢性阻塞性肺疾病急性加重期全身炎症的病因及生物标志物]
Rev Med Chil. 2012 Jan;140(1):10-8. Epub 2012 Apr 12.
2
Inflammatory changes, recovery and recurrence at COPD exacerbation.慢性阻塞性肺疾病急性加重期的炎症变化、恢复及复发
Eur Respir J. 2007 Mar;29(3):527-34. doi: 10.1183/09031936.00092506. Epub 2006 Nov 15.
3
Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.降钙素原和C反应蛋白无法区分需要前往急诊科就诊的慢性阻塞性肺疾病急性加重患者是细菌感染还是病毒感染。
Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:767-74. doi: 10.2147/COPD.S76740. eCollection 2015.
4
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病新细菌菌株加重的炎症特征
Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7. doi: 10.1164/rccm.200708-1234OC. Epub 2007 Dec 13.
5
Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的全身及上下气道炎症
Am J Respir Crit Care Med. 2006 Jan 1;173(1):71-8. doi: 10.1164/rccm.200505-704OC. Epub 2005 Sep 22.
6
Inflammatory response in acute viral exacerbations of COPD.慢性阻塞性肺疾病急性病毒加重期的炎症反应
Infection. 2008 Oct;36(5):427-33. doi: 10.1007/s15010-008-7327-5. Epub 2008 Sep 15.
7
[Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病稳定期戒烟者的全身炎症反应]
Rev Med Chil. 2010 Aug;138(8):957-64. Epub 2010 Nov 26.
8
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的炎症生物标志物与加重。
JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.
9
Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.稳定期和加重期慢性阻塞性肺疾病患者循环血管内皮生长因子和全身炎症标志物
Clin Sci (Lond). 2008 Oct;115(7):225-32. doi: 10.1042/CS20070382.
10
C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.慢性阻塞性肺疾病急性加重期门诊患者的C反应蛋白:其与微生物病因及严重程度的关系
Int J Chron Obstruct Pulmon Dis. 2016 Oct 21;11:2633-2640. doi: 10.2147/COPD.S117129. eCollection 2016.

引用本文的文献

1
Hypercoagulable State in COPD-A Comprehensive Literature Review.慢性阻塞性肺疾病中的高凝状态——一项全面的文献综述
Diagnostics (Basel). 2021 Aug 10;11(8):1447. doi: 10.3390/diagnostics11081447.
2
Role of metformin in treatment of patients with chronic obstructive pulmonary disease: a systematic review.二甲双胍在慢性阻塞性肺疾病患者治疗中的作用:一项系统评价
J Thorac Dis. 2019 Oct;11(10):4371-4378. doi: 10.21037/jtd.2019.09.84.
3
Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
慢性阻塞性肺疾病急性加重期细菌感染:系统评价和荟萃分析。
Infection. 2020 Feb;48(1):19-35. doi: 10.1007/s15010-019-01350-1. Epub 2019 Sep 3.
4
Can mean platelet volume and neutrophil-to-lymphocyte ratio be biomarkers of acute exacerbation of bronchiectasis in children?平均血小板体积和中性粒细胞与淋巴细胞比值能否作为儿童支气管扩张症急性加重的生物标志物?
Cent Eur J Immunol. 2017;42(4):358-362. doi: 10.5114/ceji.2017.72808. Epub 2017 Dec 30.
5
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.血液纤维蛋白原作为慢性阻塞性肺疾病的生物标志物。
Thorax. 2013 Jul;68(7):670-6. doi: 10.1136/thoraxjnl-2012-201871. Epub 2012 Jun 28.